How does Dapagliflozin work? Understanding SGLT2 inhibitors.

(6:57)

Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors

(2:49)

When Should We Use SGLT2 Inhibitors?

(12:28)

SGLT2 Inhibitors Mechanism of Action

(1:44)

SGLT2 Inhibitors are Associated With Reduced CV Disease in Type 2 Diabetes

(5:7)

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?

(49:14)

Nephroprotection 2025: \

(56:39)

SGLT2 Inhibitors in Chronic Kidney Disease

(9:6)

Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists

(7:43)

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

(35:24)

The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to T...

(29:16)

How SGLT2 Inhibitors Protect The Kidney

(16:24)

Cardiovascular Benefit With SGLT2 Inhibition

(2:27)

A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease

(1:6:15)

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

(6:11)

Diabetes medications - SGLT2 inhibitors - Tradenames

(4:56)

SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In

(15:34)

SGLT2 Inhibitors in T1D: 'People Are Using Them Now'

(6:58)

SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF

(8:28)

SGLT2 inhibition in type 1 diabetes patients | John Wilding

(3:44)